[Clinical significance of heterozygosity loss at Mfn2 gene in hepatocellular carcinoma]. 2010

Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

To investigate the loss of heterozygosity (LOH) at mitofusin-2 (Mfn2) gene in hepatocellular carcinoma (HCC) and its clinicopathological significance. Four high polymorphic microsatellite markers flanking Mfn2 were selected for LOH analysis in 29 cases of HCC. The frequencies of LOH on D1S2667, D1S2740, D1S434 and D1S228 were 21%, 23%, 21% and 22%, respectively. LOH at Mfn2 was closely correlated with tumor size, age, capsule, differentiation and t HBV infection (P<0.05), not with gender, thrombosis, cirrhosis and serum AFP levels (P>0.05). LOH at Mfn2 gene in HCC is associated with the clinicopathological features of patients.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D019656 Loss of Heterozygosity The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. Allelic Loss,Heterozygosity, Loss of,Allelic Losses,Heterozygosity Loss

Related Publications

Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
April 2004, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
February 1993, Nihon rinsho. Japanese journal of clinical medicine,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
March 2008, World journal of gastroenterology,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
July 2002, Clinical cancer research : an official journal of the American Association for Cancer Research,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
December 2007, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
August 1991, Cancer research,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
August 2002, Cancer research,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
May 2005, World journal of gastroenterology,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
January 1997, Journal of cancer research and clinical oncology,
Li Qu, and Wei-Ling Wang, and Jian-Feng Wei, and Wu-Hua Zhou, and Shu-Sen Zheng
November 1989, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!